site stats

Cellectar biosciences inc stock price

WebComplete Cellectar Biosciences Inc. stock information by Barron's. View real-time CLRB stock price and news, along with industry-best analysis. WebAVID BIOSERVICES INC has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of …

Cellectar Biosciences, Inc. (CLRB) Stock Price, News, Quote & History

WebCellectar Biosciences lowest stock price was $1.25 and its highest was $7.90 in the past 12 months. What is Cellectar Biosciences’s market cap? ... Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse ... WebStock analysis for Cellectar Biosciences Inc (NVLT) including stock price, stock chart, company news, key statistics, fundamentals and company profile. dan gibby mastering the markets contents https://jrwebsterhouse.com

CLRB: Cellectar Biosciences Inc - Stock Price, Quote and News

WebCellectar Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CLRB stock price. Dow Jones, a News Corp company About WSJ WebMar 8, 2024 · Cellectar Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $25.50.See the top stocks recommended by analysts >>The company has a one-year high of $10.31 and a one-year low of $1.75. Currently, Cellectar Biosciences has an average volume of 36.41K. WebThe Wall Street analyst predicted. that Cellectar Biosciences's share price could reach $4.00 by Nov 4, 2024. The average Cellectar Biosciences stock price prediction forecasts a potential upside of 187.77% from the current CLRB share price of $1.39. dangie bros try not to say no challenge

Cellectar Biosciences, Inc. (CLRB) stock price, news, quote

Category:Is Cellectar Biosciences Inc (CLRB) Stock a Good Investment?

Tags:Cellectar biosciences inc stock price

Cellectar biosciences inc stock price

Cellectar Biosciences Inc Stock Forecast, Predictions & Price Target

WebApr 14, 2024 · Cellectar Biosciences Price Performance Shares of NASDAQ:CLRB opened at $1.38 on Friday. The company has a market capitalization of $13.44 million, a … WebCellectar Biosciences is focused on the discovery and development of drugs for the treatment of cancer. The company is developing proprietary drugs independently and …

Cellectar biosciences inc stock price

Did you know?

WebCellectar Biosciences reports FY22 EPS ($4.05), consensus ($3.91) March 9, 2024TipRanks. Cellectar to Participate at Upcoming Banking Conferences March 8, … WebCellectar Biosciences Inc. research and ratings by Barron's. View CLRB revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $20.00: Low ...

WebFinancial summary. BRIEF: For the fiscal year ended 31 December 2024, Cellectar Biosciences Inc revenues was not reported. Net loss increased 60% to $24.1M. Higher net loss reflects Reaserch and development increase of 74% to $17.5M (expense), General and administrative increase of 16% to $5.5M (expense), General and administrative increase ... WebCellectar Biosciences, Inc. Common Stock (CLRB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to main content Market …

WebCellectar Biosciences stock price target cut to $7.00 from $12.50 at Maxim Group Nov. 8, 2024 at 11:09 a.m. ET by Tomi Kilgore Cellectar Biosciences started at outperform with … WebCellectar Biosciences Announces Closing of Concurrent Registered Direct and Private Placement Offerings of Approximately $10.7 Million Priced At-The-Market Under Nasdaq …

WebDec 31, 2024 · Research Cellectar Biosciences, Inc. (CLRB) stock with daily updated analysis. Home Markets Discover Watchlist Portfolios Screener. Stocks / United States / Pharmaceuticals & Biotech; Cellectar Biosciences NasdaqCM:CLRB Stock Report. Last Price. US$1.71. Market Cap. US$15.3m. 7D. 10.3%. 1Y-74.2%. Updated.

WebCellectar Biosciences Inc. options quotes data for sells and puts, including CLRB last price, change and volume. birmingham wholesale autoWebAll. FLORHAM PARK, N.J., March 09, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the year ended December 31, 2024 and provided a … dangie bros brothersWebThe latest price target for . Cellectar Biosciences (NASDAQ: CLRB) was reported by HC Wainwright & Co. on Friday, November 4, 2024.The analyst firm set a price target for 4.00 expecting CLRB to ... dang if we didn\u0027t lyricsWebThe purpose of this 2015 Stock Incentive Plan (the “Plan”) is to encourage and enable officers and employees of, and other persons providing services to, Cellectar Biosciences, Inc. (the “Company”) and its Subsidiaries (as defined below) to acquire a proprietary interest in the Company. dangie brothers agesWeb9 rows · 1 day ago · Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the ... dangie wellness servicesWebAll. FLORHAM PARK, N.J., March 09, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused … birmingham wheels adventure parkWebApr 6, 2024 · Cellectar Biosciences, Inc. (CLRB) NASDAQ: CLRB · IEX Real-Time Price · USD. Add to Watchlist 1.40 ... According to 10 stock analysts, the average 12-month stock price forecast for CLRB stock is $13.52, which predicts an increase of 865.71%. The lowest target is $7.07 and the highest is $21. birmingham where to stay